These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 113883)

  • 21. Experimental atherosclerosis in rabbits: platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclin.
    Zmuda A; Dembinska-Kiec A; Chytkowski A; Gryglewski RJ
    Prostaglandins; 1977; 14(6):1035-42. PubMed ID: 341225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Platelet aggregation and endogenous prostaglandins and thromboxane (author's transl)].
    Katori M
    No Shinkei Geka; 1980 Aug; 8(8):717-22. PubMed ID: 6999371
    [No Abstract]   [Full Text] [Related]  

  • 23. Biologic interaction of prostaglandin, thromboxane and prostacyclin: potential clinical applications.
    Bell TG; Smith WL; Oxender WD
    J Environ Pathol Toxicol Oncol; 1986; 6(3-4):191-201. PubMed ID: 3012063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostacyclin-thromboxane interactions in the platelet-perfused in vitro heart.
    Schrör K; Köhler P; Müller M; Peskar BA; Rösen P
    Am J Physiol; 1981 Jul; 241(1):H18-25. PubMed ID: 6264810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical significance of prostaglandins and other arachidonic acid metabolites. Prostacyclin (PGI2), thromboxane A2, leukotriene].
    Oelz O
    Ther Umsch; 1982 Oct; 39(10):751-8. PubMed ID: 6760444
    [No Abstract]   [Full Text] [Related]  

  • 26. One, two, three or more pathways for platelet aggregation.
    Vargaftig BB; Chignard M; Le Couedic JP; Benveniste J
    Acta Med Scand Suppl; 1980; 642():23-9. PubMed ID: 6779505
    [No Abstract]   [Full Text] [Related]  

  • 27. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostaglandins and platelet function.
    Chaikhouni A
    J S C Med Assoc; 1983 Jun; 79(6):332-6. PubMed ID: 6350704
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostaglandins, platelets, and atherosclerosis.
    Gryglewski RJ
    CRC Crit Rev Biochem; 1980; 7(4):291-338. PubMed ID: 6771102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for inhibitors of prostaglandin and thromboxane biosynthesis.
    Gryglewski RJ
    Adv Lipid Res; 1978; 16():327-44. PubMed ID: 102130
    [No Abstract]   [Full Text] [Related]  

  • 31. Alterations of the prostacyclin-thromboxane ratio in streptozotocin induced diabetic rats.
    Karpen CW; Pritchard KA; Merola AJ; Panganamala RV
    Prostaglandins Leukot Med; 1982 Feb; 8(2):93-103. PubMed ID: 6804992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis.
    Moncada S; Amezcua JL
    Haemostasis; 1979; 8(3-5):252-65. PubMed ID: 389758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The possible roles of prostaglandins and related compounds in endometrial bleeding. A mini-review.
    Granström E; Swahn ML; Lundström V
    Acta Obstet Gynecol Scand Suppl; 1983; 113():91-9. PubMed ID: 6407272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-thrombotic effects of prostacyclin.
    Vane JR; Moncada S
    Acta Med Scand Suppl; 1980; 642():11-22. PubMed ID: 7006326
    [No Abstract]   [Full Text] [Related]  

  • 35. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

  • 36. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI; Lavrenova NIu; Goloborodova IV
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandins and platelets.
    Mustard JF; Kinlough-Rathbone RL; Packham MA
    Annu Rev Med; 1980; 31():89-96. PubMed ID: 6994628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The arachidonic acid metabolites (prostaglandins, thromboxanes, prostacyclin, leucotrienes):basics and clinical implications (author's transl)].
    Oelz O
    Ther Umsch; 1979 Oct; 36(10):882-8. PubMed ID: 119331
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.